Panagora Asset Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Panagora Asset Management’s Portfolio NVLN Stock Details NVLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,101	Closed	-$2K	–	2772
2019 Q2	$2K	Buy	+2,101	New	+$2.34K	﹤0.01%	2547
2018 Q2	–	Sell	-15,421	Closed	-$54K	–	2459
2018 Q1	$54K	Buy	+15,421	New	+$65.4K	﹤0.01%	2011

Other funds holding NVLN

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Panagora Asset Management's NVLN Position: Q3 2019 in Review

Panagora Asset Management sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q3 2019, closing a stake of 2,101 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in NVLN in Q1 2018 and held it in 2 quarters. The position peaked at $54K in Q1 2018. 31 funds tracked by Wall St. Rank hold NVLN as of Q3 2019.

Panagora Asset Management reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 2,101 Novelion Therapeutics Inc. Common Shares shares in Q3 2019, an estimated $2K.
Panagora Asset Management first reported a position in Novelion Therapeutics Inc. Common Shares in Q1 2018 and held it in 2 quarters.
Panagora Asset Management's Novelion Therapeutics Inc. Common Shares position peaked at $54K in Q1 2018.
31 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.